Sign in
Biosimilars: What Can Retina Learn from Oncology?
Kathy W Oubre, MS
Updates from the Field
2022
Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019
National Cohort Study on New Oral Hypoglycemic Agents in Diabetic Retinopathy Progression
Ehsan Rahimy, MD
2023
Category: AMD-Neovascular